COMPARATIVE STUDY ON THREE DOSES OF ESMOLOL TO ATTENUATE THE HAEMODYNAMIC STRESS RESPONSE DURING LARYNGOSCOPY AND ENDOTRACHEAL INTUBATION

BACKGROUND The advantage of IV Esmolol due to its ultra-short action seem to be ideal to control intense but brief sympathetic stimulation following endotracheal intubation, inspired us to conduct a study in which we compared the three doses of Esmolol to attenuate the haemodynamic stress response during Laryngoscopy and Endotracheal intubation. AIM This study was done to compare the varying doses of IV Esmolol in attenuating the haemodynamic stress response to laryngoscopy and endotracheal intubation. METHODS AND MATERIALS Sixty ASA I and II patients undergoing elective surgical procedure under general anaesthesia with endotracheal intubation were included in this study. Patients belonging to age group 20-50 years of both the sexes were included. It is prospective double blind randomized study. The study was approved by the Ethical Committee and was randomly grouped into three groups. Group A (Esmolol 5 mg/kg) 20 patients were given Esmolol 0.5 mg/kg IV 2 minutes before intubation. Group B (Esmolol 1.0 mg/kg)-20 Patients were given Esmolol 1 mg/kg IV 2 minutes before intubation. Group C (Esmolol 1.5 mg/kg) 20 patients were given Esmolol 1.5 mg/kg IV 2 minutes before intubation. STATISTICAL ANALYSIS Heart rate, systolic Blood pressure, Diastolic pressure and mean arterial pressure were recorded using MS Excel software and analysed using STATA software for determining the statistical significance. ANOVA test was used to determine the significance among three groups. Student's 't' test was used to compare the three groups in mean values of various parameters. The P value taken for signification is <0.05. RESULTS The dose of Esmolol 1.5 mg/kg (Group C) to be effective in attenuating the haemodynamic responses during laryngoscopy and ET intubation with no major adverse effects when compared to 0.5 and 1.0 mg/kg. CONCLUSION We found that the dose of Esmolol 1.5 mg/kg (Group C) to be effective in attenuating the haemodynamic responses during laryngoscopy and endotracheal intubation with no major adverse effects of Esmolol.